The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 210 participants.

Also called NCT02646267

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02646267
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02646267. Randomized; no masking; primary purpose treatment. Start 2016-03 (registry gives no type); primary completion 2018-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety Study of Dabigatran and Warfarin to Non-valvular Atrial Fibrillation Patients
Intervention (Drug)
standard intensity warfarin
Intervention (Drug)
low intensity warfarin
Intervention (Drug)
dabigatran etexilate
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct02646267
Content hash
9bf6629512bf37a969f264d916b825cf14f5967f1ee7963c95c377372b4fd640